Ulys
Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:
- As of March 31, 2013, Ulys has $65.03M in assets under management (AUM). Assets under management grew from a total value of $0 to $65.03M.
- Independent of market fluctuations, Ulys was a net seller by $0 worth of stocks in the most recent quarter.
Ulys portfolio companies for quarter ending March 2013
| Ticker | Name | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals | 99.83 | 29782609 | 2.18 | 2.12 |
| Ceres | 0.17 | 31131 | 3.47 | 0.00 |
Past 13F-HR SEC Filings for Ulys
- ULYS 2012 Q4 - filed Feb. 12, 2013
- ULYS 2012 Q3 - filed Nov. 14, 2012
- Ulys 2012 Q2 - filed Aug. 14, 2012
- ULYS 2012 Q1 - filed May 15, 2012
- Ulys 2011 Q4 - filed Feb. 14, 2012
- Ulys 2011 Q3 - filed Nov. 14, 2011